Jan-Ingmar Flock

Title: Jan-Ingmar Flock: Innovator in Biotechnology

Introduction

Jan-Ingmar Flock is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of proteins with therapeutic and diagnostic applications. His work focuses on innovative solutions that address medical challenges.

Latest Patents

Jan-Ingmar Flock holds a patent for a fibrinogen binding protein originating from coagulase-negative staphylococcus. This invention includes a new fibrinogen binding protein or polypeptide, biotechnological methods for producing the protein, and a recombinant DNA molecule coding for the protein or its fragments. The patent also covers micro-organisms containing this recombinant DNA molecule. Furthermore, it outlines the therapeutic and diagnostic uses of the protein and DNA, including a diagnostic kit for detecting coagulase-negative staphylococci and a vaccine composition.

Career Highlights

Throughout his career, Jan-Ingmar Flock has demonstrated a commitment to advancing biotechnological research. His innovative approaches have led to the development of valuable medical tools that can improve patient outcomes. His work exemplifies the intersection of science and practical application in healthcare.

Collaborations

Jan-Ingmar Flock has collaborated with notable colleagues, including Martin Kjell Lindberg and Martin P Nilsson. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Jan-Ingmar Flock is a distinguished inventor whose work in biotechnology has the potential to impact medical diagnostics and therapeutics significantly. His innovative contributions continue to pave the way for advancements in the field.